Trial Profile
Ramelteon (melatonin receptor agonist) for neuromuscular degenerative disease and neuroimmunological disease;examination for safety.
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 11 Sep 2011
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary)
- Indications Autoimmune diseases of the nervous system; Neurodegenerative disorders; Neuromuscular disorders
- Focus Pharmacodynamics
- 11 Sep 2011 New trial record